Friday, June 26, 2020
11 AM EDT (NA) | 4 PM BST (UK) | 5 PM CEST (EU-Central)
The clinical trial environment was already evolving at a rapid pace before the presence of COVID-19, but now speed and efficiency are paramount. Expectations and performance of an Interactive Response Technology (IRT) partner have now intensified, as sponsors require a shorter time to go live, while requiring advancements in risk mitigation and ensuring the drug can get to the patient.
In this insightful webinar, we will present a look at current trial challenges sponsors are facing, how novel IRT products are actively helping sponsors in their fight against COVID-19, and offer practical tips that will keep your study conduct in compliance and progressing amidst a pandemic.
- The impact of today’s environment on conducting clinical trials and ensuring patient safety
- How IRT implementation speed can be accelerated to account for evolving trial conduct
- Practical tips for streamlining your trials and preventing supply chain disruption, all while remaining compliant
Head of Strategic Relationship Management, EU, Almac Clinical Technologies
In 1999, Mike joined a leading central laboratory provider in London in a Project Management capacity before moving to Almac Clinical Technologies in 2002 as a Project Manager. Mike has now been with Almac over 17 years, working in various roles of increasing responsibility, from Project Management to Operational Management, and now, in a tactical commercial role.
Mike is currently Head of Strategic Relationship Management, EU and oversees several key clients along with developing new and exciting business in EU and beyond with Almac’s leading Interactive Response Technology.
Manager, Clinical Project Services, Almac Clinical Technologies
Here, Brian has enjoyed developing and increasing efficiency in IRT design and project management for the past 11 years. Currently, Brian leads the UK Design Management Team at Almac Clinical Technologies.